Doximity Inc. (DOCS:NYE) Analysts rate with a Buy, $55 target

STA Research
by: STA Research

Analysts rate Doximity Inc. stock with a consensus Buy rating with a 12-month average target price of $55.76 per share

Based on the Doximity Inc. stock forecasts from 13 analysts, the average analyst target price for Doximity Inc. is USD 55.76 over the next 12 months. Doximity Inc.’s average analyst rating is Buy. Stock Target Advisor’s own stock analysis of Doximity Inc. is Bullish, which is based on 8 positive signals and 3 negative signals. At the last closing, Doximity Inc.’s stock price was USD 30.31. Doximity Inc.’s stock price has changed by -0.94% over the past week, -20.00% over the past month and +0.00% over the last year.

In the United States, Doximity, Inc. runs a cloud-based digital platform for medical practitioners. The company’s cloud-based platform gives users access to tools designed specifically for medical professionals, allowing them to connect with colleagues, coordinate patient care, conduct virtual patient visits, remain current on medical news and research, and manage their careers. Pharmaceutical corporations and health systems are its primary clients. 3MD Communications, Inc. was the company’s previous name until June 2010, when it changed to Doximity, Inc. Doximity, Inc. is based in San Francisco, California, and was founded in 2010.

Recent Analyst Ratings for Doximity Inc:

 

What we like:

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior return on equity

The company management has delivered a better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered a better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered a better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What we don’t like:

Overpriced compared to book value

The stock is trading high compared to its peers’ median on a price to book value basis.

Overpriced on a cash flow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering buying.

Overpriced on a free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering buying.

 

 

Leave a Reply

Your email address will not be published.